![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 29, 25870-25876, July 19, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
§,
, and
**
From the
Department of Molecular Microbiology,
Washington University School of Medicine, St. Louis, Missouri 63110 and
the ¶ Laboratory of Molecular Parasitology, Department of
Pathobiology, College of Veterinary Medicine, University of
Illinois at Urbana-Champaign, Urbana, Illinois 61802
Received for publication, March 15, 2002, and in revised form, May 7, 2002
| |
ABSTRACT |
|---|
|
|
|---|
Calcium-mediated microneme secretion in
Toxoplasma gondii is stimulated by contact with host cells,
resulting in the discharge of adhesins that mediate attachment. The
intracellular source of calcium and the signaling pathway(s) triggering
release have not been characterized, prompting our search for mediators
of calcium signaling and microneme secretion in T. gondii.
We identified two stimuli of microneme secretion, ryanodine and
caffeine, which enhanced release of calcium from parasite intracellular
stores. Ethanol, a previously characterized trigger of microneme
secretion, stimulated an increase in parasite inositol
1,4,5-triphosphate, implying that this second messenger may mediate
intracellular calcium release. Consistent with this observation,
xestospongin C, an inositol 1,4,5-triphosphate receptor antagonist,
inhibited microneme secretion and blocked parasite attachment and
invasion of host cells. Collectively, these results suggest that
T. gondii possess an intracellular calcium release channel
with properties of the inositol 1,4,5-triphosphate/ryanodine receptor
superfamily. Intracellular calcium channels, previously studied almost
exclusively in multicellular animals, appear to also be critical to the
control of parasite calcium during the initial steps of host cell entry.
Apicomplexans are unicellular parasites that must enter cells to
replicate. Members of this phylum share a common vulnerability when the
process of invasion is compromised, yet diseases caused by
apicomplexans remain among the most difficult to cure. The invasion
process is rapid and marked by the sequential secretion of parasite
organelles. Micronemes, rhoptries, and dense granule contents are
released by invading parasites and participate in attachment, vacuole
formation, and intracellular survival (1). Understanding the mechanisms
regulating parasite secretion could thus be useful in the design of new
therapeutic strategies aimed at blocking invasion.
Micronemes are the first secretory organelles to be discharged during
Toxoplasma gondii invasion. Microneme proteins possess a
variety of adhesive domains and include soluble and transmembrane forms
(2, 3). Their release appears highly regulated in that host cell
contact triggers a burst of microneme release (1). Binding studies
suggest that microneme proteins participate in attachment to host cell
surfaces (4-7) and that the transmembrane form of the adhesin MIC2 may
link parasite and host cell membranes during invasion.
Previous studies demonstrated that increases in intracellular calcium
([Ca2+]i) mediate microneme
secretion in T. gondii. For example, association of T. gondii tachyzoites with host cells results in increases in
parasite [Ca2+]i (8) and chelation
of T. gondii [Ca2+]i
blocks microneme secretion and invasion (9). Moreover, reagents that
raise T. gondii [Ca2+]i
levels stimulate microneme discharge in the absence of host cells (10).
These include Ca2+ ionophores ionomycin and A23187, as well
as the sarco-endoplasmic reticulum ATPase inhibitor thapsigargin (10).
Identification of alcohols as potent artificial triggers of microneme
secretion led to studies demonstrating that ethanol also raises
parasite [Ca2+]i levels (11).
T. gondii possess several intracellular stores of
Ca2+, including the acidocalcisomes (12), mitochondria, and
the endoplasmic reticulum (13). Whether all or some of these stores participate in microneme secretion during host cell invasion is unknown. The mechanism of Ca2+-mediated microneme release
in both artificially triggered and natural microneme secretion during
invasion remains largely undefined.
Regulated exocytosis is associated with fluxes in
[Ca2+]i, although the exact step
requiring Ca2+ is unclear and may depend on the system
being studied (14). Ca2+ signaling involves the
mobilization of Ca2+ from two sources: intracellular stores
and the extracellular medium. In mammalian cells, the sarco-endoplasmic
reticulum is a commonly utilized source of readily accessible
[Ca2+]i, which can be rapidly
mobilized under a variety of stimuli. Two types of sarco-endoplasmic
reticulum Ca2+ release channels have been identified in
multicellular animals: the
IP31 receptor and
the ryanodine receptor, which are structurally similar and are thought
to be evolutionarily related (15). Binding of the second messenger
IP3 to its receptor releases Ca2+ into the
cytosol, whereas ryanodine receptors are modulated in some cells by
cyclic ADP-ribose (16). This release of intracellular Ca2+
can in some manner signal the activation of Ca2+ entry, a
process known as capacitative Ca2+ entry (17).
Neither IP3, ryanodine receptors, or capacitative
Ca2+ entry have been identified in unicellular organisms,
including yeast and protozoa. However, evidence linking IP3
to [Ca2+]i flux has been described
in several unicellular systems. Treatment of membrane vesicles from
Candida albicans (18) or Plasmodium chabaudi (19)
with IP3 results in Ca2+ release and is blocked
by the IP3 receptor antagonist heparin. IP3
induces Ca2+ release from Euglena gracilis
microsomes in a dose-dependent manner (20). Carbachol
stimulation of Trypanosoma cruzi results in increased
[Ca2+]i and IP3 (21).
In characean algae, introduction of IP3 produces action
potentials, an event known to involve increases in cytoplasmic
Ca2+ (22). Collectively, these studies indicate a potential
role for IP3 in Ca2+-mediated signaling events
among early branching unicellular eukaryotes.
We were interested in determining whether IP3 functions as
a mediator of microneme secretion by increasing parasite
[Ca2+]i. In this work, we present
evidence that T. gondii may possess intracellular release
channels of the IP3/ryanodine receptor superfamily.
Chemicals--
Caffeine, EGTA, and ryanodine were purchased from
Sigma. BAPTA-AM and xestospongin C were purchased from Calbiochem. The
BiotrakTM [3H]IP3 assay system
was purchased from Amersham Biosciences. All other reagents were
analytical grade. Drugs were resuspended as 100× stock solutions in
either distilled water or Me2SO.
Parasite Culture--
T. gondii strain RH and the
lacZ-expressing clone 2F were maintained as tachyzoites in
human foreskin fibroblast cells as described (23). For Ca2+
measurement experiments, RH tachyzoites were maintained in bovine turbinate cells (ATCC CRL 1390) (12). All experiments used freshly lysed out parasites purified by passage through a 23-gauge needle and
filtration through a 3 micron Nucleopore membrane. All cultures tested
free of Mycoplasma using the GenProbeTM
mycoplasma detection system.
SDS-Polyacrylamide Gel Electrophoresis and Western
Blotting--
SDS-PAGE was performed in 7% mini-gels under reducing
conditions and transferred to nitrocellulose as previously described (10). Western blotting was performed with mouse anti-TgMIC2 monoclonal
antibody 6D10 (ascites, 1:10,000) (10), mouse anti-TgMIC4 monoclonal
antibody 5B1 (supernatant, 1:10) (24), and rabbit polyclonal
anti-TgACT1 actin antibody (1:10,000) (25). Mouse anti
IP3 Quantification--
Tachyzoites were resuspended
at 3 × 109/ml in 10 mM HEPES, 1 mM EGTA in Hanks' balanced salt with no calcium chloride,
magnesium chloride, magnesium sulfate, or sodium bicarbonate and split
into two tubes. After equilibration at 37 °C for 5 min,
secretagogues or a solvent control were added (time 0). At 30-60 s
intervals 0.1 ml of parasites were removed and added to an equal volume of ice-cold 15% trichloroacetic acid. Tubes were vortexed and spun at
4 °C for 15 min at 2000 × g. Supernatants were
extracted three times with 10 volumes of water-saturated ether and
adjusted to pH 7.5 with 1 M sodium bicarbonate. Pellets
were resuspended in SDS-PAGE sample buffer for confirmation of
secretion stimulation by Western blotting of TgMIC2. IP3 in
ether-extracted supernatants was measured in duplicate based on the
potential of the parasite samples containing IP3 to
displace [3H]IP3 from a bovine
IP3 receptor as described in the Amersham BiotrakTM protocol. Basal levels of IP3 ranged
from 0.4 to 0.6 pmol/108 parasites.
Microneme Secretion Assay--
Tachyzoites were resuspended at
108/ml in Dulbecco's modified Eagle's medium, 1% fetal
bovine serum, and 20 mM HEPES, pH 7.5 at 18 °C in 1.5 ml
microcentrifuge tubes. Pretreatment with stock solutions of drugs
proceeded for 15 min before transferring parasites to 37 °C for 2 min to stimulate secretion followed by transfer to a wet ice bath. In
parallel, 100 µM BAPTA-AM was loaded for 10 min at
18 °C, while 10 mM EGTA was added immediately prior to
secretagogue stimulation to minimize leaching of intracellular Ca2+ stores. Parasite supernatants were separated from
pellets by centrifugation at 4 °C and run on 7% SDS-PAGE gels next
to pellet dilutions to indicate the secreted and cellular forms of
TgMIC2. Inadvertent lysis of parasites was monitored by the release of constitutively expressed Measurement of Parasite
[Ca2+]i--
After being harvested,
tachyzoites were washed twice at 500 × g for 10 min at
room temperature in buffer A (116 mM NaCl/5.4 mM KCl/0.8 mM MgSO4/5.5
mM D-glucose/50 mM HEPES, pH 7.4).
Parasites were resuspended to a final density of 109
cells/ml in loading buffer, which consisted of buffer A plus 1.5%
(w/v) sucrose and 6 µM fura-2/AM. The suspensions were
incubated for 30 min at 25 °C. Subsequently, the cells were washed
twice with buffer A to remove extracellular dye. Parasites were
resuspended to a final density of 109 cells/ml in buffer A
and kept in ice. Parasites were viable for several hours under these
conditions. For fluorescence measurements, a 50-µl aliquot of the
cell suspension was diluted into 2.5 ml of buffer A (2 × 107 cells/ml final density) in a cuvette placed into a
Hitachi F-2000 spectrofluorometer at room temperature. For measurements
with fura-2, excitation was at 340 and 380 nm and emission was at 510 nm. The fura-2 fluorescence response to
[Ca2+]i was calibrated from the
ratio of fluorescence values at 340 and 380 nm after subtraction of the
background fluorescence of the cells at 340 and 380 nm.
[Ca2+]i was calculated by
titration with different concentrations of Ca2+/EGTA
buffers. Traces shown are representative of at least three independent
experiments conducted on separate cell preparations. Variations in the
values of [Ca2+]i between
experiments with different cell preparations were less than 20%.
Attachment and Invasion Assays--
Tachyzoite invasion of human
foreskin fibroblasts grown to confluence in 24-well plates was
quantified by colorimetric detection of Ryanodine Stimulates Ca2+-mediated Microneme
Secretion--
Ryanodine has been shown to mediate increases in
[Ca2+]i in a variety of
multicellular organisms (26). To determine whether ryanodine stimulated
Toxoplasma microneme secretion, we treated tachyzoites with
ryanodine at concentrations ranging from 1 nM to 100 µM, removed the cells by centrifugation, and examined secreted proteins MIC2 and MIC4 present in supernatants by Western blotting. MIC2 is a convenient marker for microneme secretion because
the secreted 95-100-kDa form (sMIC2) is released into supernatants,
while the cell-associated 115-kDa form (cMIC2) remains in the parasite
pellet (27). Similarly, the secreted form of MIC4 is 70-kDa, while
cell-associated MIC4 is 72 kDa. Constitutive expression of
Secretion of MIC2 and MIC4 was stimulated by ryanodine at doses from 1 nM to 10 µM but inhibited at 100 µM when compared with parasites treated with
Me2SO (Fig. 1A).
The inhibition of microneme secretion at 100 µM is
consistent with previous studies indicating that high doses keep the
ryanodine receptor in a closed conformation (26). To determine whether
ryanodine stimulation of microneme secretion involved an increase of
[Ca2+]i from either intracellular
stores or the extracellular medium, we pretreated parasites with the
membrane-permeable calcium chelator BAPTA-AM to prevent
[Ca2+]i increases (8) or added
EGTA to the parasites immediately prior to addition of ryanodine to
chelate extracellular Ca2+ and prevent Ca2+
entry (12). BAPTA-AM pretreatment inhibited microneme secretion upon
stimulation with 100 nM ryanodine (Fig. 1A),
indicating that ryanodine-mediated secretion required a rise in
parasite [Ca2+]i. Additionally,
EGTA also blocked ryanodine stimulation of microneme secretion, showing
that extracellular Ca2+ was required by the parasite.
Monitoring of [Ca2+]i using
fura-2-loaded parasites confirmed these results. The increase in
[Ca2+]i produced by ryanodine in
the absence of extracellular Ca2+ (with 1 mM
EGTA added to the incubation medium; Fig. 1B,
+EGTA) confirmed the hypothesis that ryanodine is able to
release Ca2+ from intracellular stores of T. gondii. Under these conditions [Ca2+]i rapidly decreased,
probably through Ca2+ efflux to the external medium or
Ca2+ uptake into other intracellular stores. In the
presence of extracellular Ca2+ a greater and sustained
response was observed upon addition of ryanodine (Fig. 1B).
Both the magnitude and duration of this elevated [Ca2+]i response were greater in
the presence of extracellular Ca2+ (Fig. 1B).
This sustained [Ca2+]i elevation
in the presence of extracellular Ca2+ could be due either
to capacitative Ca2+ entry (17) or to inhibition of
Ca2+ efflux by ryanodine as has been postulated to occur in
smooth muscle cells (28). Because treatment of tachyzoites with EGTA prevented microneme secretion (Fig. 1A) a sustained
[Ca2+]i increase is apparently
responsible for this process.
Caffeine Stimulates Ca2+-mediated Microneme
Secretion--
Caffeine is a pharmacological agonist of ryanodine
receptor Ca2+ release (26). Based on the above evidence
that T. gondii has a ryanodine-sensitive Ca2+
response, we tested caffeine for its ability to stimulate microneme secretion. Tachyzoites were incubated with caffeine at concentrations ranging from 1 µM to 1 mM before collection
of supernatants for analysis by Western blot. Caffeine stimulated
microneme secretion at all doses, while only causing minimal parasite
lysis (Fig. 2A). Additionally,
BAPTA-AM pretreatment to prevent parasite
[Ca2+]i increase (8) abrogated
caffeine-induced microneme secretion, indicating that a rise in
[Ca2+]i was required for
caffeine's effect. Unlike ryanodine, caffeine's ability to stimulate
microneme secretion did not require extracellular Ca2+, as
chelation with EGTA prior to addition of caffeine did not affect
secretion of TgMIC2 and TgMIC4 (Fig. 2A).
Caffeine treatment also increased parasite
[Ca2+]i, as shown by direct
monitoring of Ca2+ using fura-2-loaded tachyzoites (Fig.
2B). Unlike ryanodine, caffeine resulted in a more sustained
[Ca2+]i increase in the absence of
extracellular Ca2+. The lack of inhibition of microneme
secretion by addition of EGTA could be related to either this more
sustained response or to a closer spatial association between the
caffeine-sensitive channels and the micronemes. Collectively, these
results indicate that caffeine increased
[Ca2+]i, which in turn stimulated
microneme secretion in T. gondii.
Toxoplasma appears very sensitive to the effects of
caffeine, as stimulation of secretion was observed down to micromolar levels while this compound is typically used at millimolar doses in
other systems (29). Caffeine has at least two major effects on
mammalian cells: stimulation of ryanodine receptor-mediated Ca2+ release and inhibition of cyclic nucleotide
phosphodiesterases (reviewed in Ref. 29). To address the possibility
that caffeine stimulated microneme secretion through inhibition of
cyclic nucleotide phosphodiesterases, we tested several additional
compounds known to act on this pathway. Treatment with
isobutylmethylxanthine, a nonspecific phosphodiesterase
inhibitor, stimulated microneme secretion at 100 µM.2 However,
treatment with forskolin, which elevates cyclic AMP in T. gondii (30), 8-bromo-cyclic-AMP (also expected to increase cyclic
AMP), and 8-bromo-cyclic GMP (expected to increase cyclic GMP)
had no effect on microneme secretion.2
Ethanol Increases Parasite IP3--
Ethanol is a
potent trigger of microneme secretion in the absence of host cells
(11). Because the effects of ethanol correlate with increases in
parasite [Ca2+]i, we were
interested in determining whether the second messenger IP3
was generated. Parasite IP3 was measured using a commercially available radioreceptor assay. A rapid increase in IP3 was observed after addition of 1% (171 mM)
ethanol to extracellular tachyzoites at 37 °C (Fig.
3A). Peak IP3
levels were reached within the first minute after secretagogue addition
in three independent experiments, with a mean maximal fold increase of
2.27 ± 1.31 compared with 0.84 ± 0.48 for the
buffer-treated control. In parallel, secretion of microneme proteins
was assayed by Western blot (Fig. 3B). IP3
release often preceded secretion of micronemal proteins, which
is consistent with its signaling activity mediating stimulation of
Ca2+ release from intracellular stores.
IP3 Receptor Antagonist Inhibits Attachment, Invasion,
and Microneme Secretion--
The possibility that
Toxoplasma contains intracellular Ca2+ release
channels of the IP3/ryanodine receptor family prompted us to examine additional drugs that could block invasion and microneme secretion through modulation of Ca2+ channels. Xestospongin
C is a membrane-permeable IP3 receptor antagonist that does
not affect IP3 binding in rabbit cerebellar microsomes
(31). Tachyzoites were pretreated with xestospongin C at doses from 10 to 0.1 µM before stimulation with ethanol or caffeine.
Secretion induced by ethanol and caffeine was reduced upon treatment
with >1 µM xestospongin C, as were the basal levels of
secretion (Fig. 4B). In
agreement with these results, Ca2+ release by addition of
either caffeine (Fig. 4C) or ethanol (Fig. 4D)
was reduced upon treatment with xestospongin C (Fig. 4, C and D). We also tested xestospongin C in attachment and
invasion assays on host cells. In parallel, tachyzoites were pretreated with different drug concentrations before addition to host cells for 20 min. Attachment assays were performed on formaldehyde-fixed host cells
for the same length of time. Xestospongin C inhibited both attachment
and invasion in a dose-dependent manner with an approximate
IC50 of 2 µM for attachment and 8 µM for invasion (Fig 4A). Treatment of
fura-2/AM-loaded parasites with 1 µM xestospongin C
reduced the increase in [Ca2+]i
upon stimulation with caffeine (Fig 4C) and ethanol (Fig
4D), paralleling the inhibition of microneme secretion
observed with this dose in Fig. 4B. Collectively, these
studies show that xestospongin C is an antagonist of
Ca2+-mediated microneme secretion, attachment, and invasion
in T. gondii.
Calcium-mediated exocytosis of T. gondii microneme
proteins is a key step in the invasion of host cells. The control of
intracellular Ca2+ levels in T. gondii is not
well characterized, prompting our search for modulators of secretion
whose target was well studied in other Ca2+ signaling
systems. We identified ryanodine and caffeine, two ryanodine receptor
agonists, as stimuli of Ca2+-mediated microneme secretion.
We also found that the second messenger IP3 was induced
upon ethanol stimulation of parasites. Finally, the IP3
receptor antagonist xestospongin C inhibited the caffeine- and
ethanol-induced increases in
[Ca2+]i, as well as preventing
microneme secretion, attachment, and invasion. Together, these results
strongly suggest that channels of the IP3/ryanodine
receptor superfamily in T. gondii mediate increases in
[Ca2+]i, which in turn promote
microneme secretion.
Ryanodine is an active component of the botanical insecticide ryania,
an alkaloid found in the shrub Ryania speciosa. Ryanodine has potent effects on a variety of multicellular organisms (25). Receptors that release calcium from intracellular stores in response to
ryanodine treatment have been described in vertebrates, where they
usually are expressed in specialized neurosecretory or muscle cells
(15). Ryanodine receptors also exist in a variety of invertebrates including crustaceans, insects, and worms; however, they have not been
described in unicellular organisms (32). At micromolar levels ryanodine
stabilizes ryanodine receptors in the open form, allowing
Ca2+ liberation from the sarco-endoplasmic lumen (26). At
higher concentrations, ryanodine receptor channels in rabbit skeletal sarcoplasmic reticulum vesicles are persistently blocked (33). We
observed a similar biphasic dose response in T. gondii, and ryanodine stimulation of microneme secretion was dependent on both intracellular and extracellular calcium. Ryanodine stimulation of
[Ca2+]i release has been shown to require
extracellular calcium as part of its Ca2+-induced
Ca2+ release mechanism, suggesting it may activate flux
through plasma membrane channels and capacitative entry (17, 26). The
induction of calcium release in T. gondii treated with
ryanodine parallels that in well studied systems, suggesting the
existence of ryanodine-responsive calcium channels in this early
branching eukaryote.
Caffeine also induced microneme secretion by T. gondii, and
was effective at doses that are 100-fold lower than its activity on
mammalian cells. Unlike ryanodine, caffeine did not require extracellular Ca2+, a result similar to that reported for
rat PC12 cells (35). In addition to acting on ryanodine-like calcium
channels, caffeine and related alkylxanthines have been shown to
inhibit cyclic nucleotide phosphodiesterases (25, 26, 33). The
resulting increases in cyclic AMP and activation of protein kinase A
can give rise to an increase in
[Ca+2]i in mammalian cells (36).
Although isobutylmethylxanthine, a nonselective phosphodiesterase
inhibitor, also stimulated microneme secretion by T. gondii,
two drugs expected to directly increase cyclic AMP, forskolin and
8-bromo-cyclic AMP, had no affect on microneme secretion. Similarly,
treatment of parasites with 8-bromo-cyclic GMP did not affect microneme
secretion. Thus, while we cannot rule out possible inhibition of
phosphodiesterases, the effect of caffeine in elevating
[Ca2+]i in T. gondii does not seem to
be due to this mechanism. A third possible mode of action is that
caffeine may inhibit the sarco-endoplasmic reticulum type ATPase
involved in refilling calcium stores. This would be consistent with the
results showing a more sustained
[Ca2+]i elevation with caffeine
than with ryanodine in the absence of extracellular Ca2+
(Fig. 2B). While this pump is not yet characterized in
T. gondii, studies in the ciliate Paramecium
tetraurelia have shown that the sarco-endoplasmic reticulum ATPase
is exquisitely sensitive to caffeine inhibition (37). Ciliates are
phylogenetically close relatives of the Apicomplexa. Determination of
whether this mechanism for caffeine also operates in T. gondii and related parasites will require further study.
Unlike paramecium, the [Ca2+]i pool in T. gondii is sensitive to thapsigargin (12); however, ethanol
stimulation of thapsigargin-pretreated parasites generates an
additional increase in [Ca2+]i
(11), implying that they also possess a thapsigargin-insensitive [Ca2+]i pool. Similarly,
pretreatment with thapsigargin prior to stimulation with caffeine or
ryanodine did not inhibit microneme secretion (data not shown),
suggesting that this same thapsigargin-insensitive pool may be
stimulated by caffeine or ryanodine.
Our studies demonstrate that IP3 acts as a second messenger
during the stimulation of tachyzoites with ethanol, a known
Ca2+-mediated trigger of microneme secretion (11). In
higher eukaryotes, IP3 induces calcium release from
channels located in the sarco-endoplasmic reticulum in a variety of
cell types (38). Typically, IP3 is produced along with
diacylglycerol after hydrolysis of phosphatidylinositol 4,5-bisphosphate by inositol phospholipid-specific phospholipase C
(PLC). In higher eukaryotes, this process is mediated by PLC- Previous evidence for IP3-responsive Ca2+
release channels in unicellular organisms has been indirect.
Entamoeba histolytica crude membranes bind radiolabeled
IP3 (44), and a cross-reacting IP3 receptor
antibody detects an appropriately sized protein in the ciliate
Blepharisma japonicum (45, 46). Combined with the present
findings, these results indicate that single-celled eukaryotes also
likely have intracellular calcium release channels that respond to
IP3. However, our attempts to identify IP3 or ryanodine receptor channels in T. gondii using a
cross-reactive antibody (mouse monoclonal antibody 34C anti-chicken
ryanodine receptor) (47) have not been successful. IP3 and
ryanodine receptors are ~40% homologous between Caenorhabditis
elegans and vertebrates, and they are likely to be significantly
more divergent in protozoa due to their early branching phylogenetic
position (48). We have analyzed the nearly complete genomes of P. falciparum (42) and Cryptosporidium parvum
(www.parvum.mic.vcu.edu/) and the Apicomplexan expressed sequence tag databases (paradb.cis.upenn.edu/) and
found that these organisms do not contain well recognized motifs for IP3 or ryanodine receptors such as SPRY and MIR domains.
Consequently, it is likely that protozoa such as T. gondii
possess intracellular calcium release channels that are unconventional
in sequence and/or function.
Our observations suggest that IP3 catalyzes
[Ca2+]i release in the parasite
through an intracellular channel related to the IP3
ryanodine receptor superfamily during T. gondii invasion of
host cells. To test whether production of IP3 was necessary for microneme secretion and host cell attachment, we utilized xestospongin C, a compound that inhibits
IP3-dependent Ca2+ release from rat
cerebellar microsomes (31) and Dictyostelium vesicles (34).
Xestospongin C acts primarily as a competitive inhibitor of
IP3 to block calcium release from IP3
receptors; however, it can also inhibit ryanodine receptors with
somewhat lower potency (31). Xestospongin C treatment of T. gondii inhibited ethanol- and caffeine-mediated secretion of
micronemes and prevented attachment and invasion of host cells.
Together, these results imply that xestospongin C inhibits microneme
secretion by modulating a T. gondii
[Ca2+]i release channel that
responds to IP3. These findings suggest that the engagement
of natural ligands during host cell invasion may also give rise to
IP3 to promote the observed increases in
[Ca2+]i in the parasite reported
previously (10).
The results of our studies using Ca2+ release channel
agonists and antagonists strongly suggest that the protozoan parasite T. gondii possess intracellular calcium release channels of
the IP3/ryanodine superfamily. Relatively low
concentrations of caffeine, ryanodine, and xestospongin C affected
microneme release, indicating that protozoa may be unusually sensitive
to these agents that affect calcium channels. While we cannot rule out
secondary effects on other pathways, the primary response observed to
all these compounds is consistent with their acting on a calcium
release channel. A model integrating our findings with a hypothetical signaling cascade is presented in Fig. 5.
We show that ethanol increases IP3 production, a second
messenger that could act to liberate the [Ca2+]i
pool. We also show that ryanodine increases
[Ca2+]i, suggesting it interacts
directly with a putative [Ca2+]i release channel
via a Ca2+-induced Ca2+ release mechanism. The
calcium-dependent stimulation of microneme secretion by
ryanodine, caffeine, or ethanol was thapsigargin-insensitive, indicating that this unique pool may be responsible for calcium signaling in parasites. During contact with host cells, it is likely
that a similar cascade is triggered to release Ca2+ from an
intracellular store and stimulate microneme secretion. A role for a
putative parasite PLC in the conversion of phosphatidylinositol bisphosphate to IP3 and diacylglycerol is suggested
by the available data but has not yet been directly demonstrated. The
responsiveness to both IP3 and ryanodine suggests that
calcium release channels may exist as two separate entities. However,
we have not excluded the intriguing possibility that protozoa possess a
single ancient channel displaying hybrid properties of both. Analysis
of calcium channels in protozoa will be illuminating to studies of the
function and evolution of eukaryotic calcium signaling proteins.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-galactosidase monoclonal antibody 40-1a (supernatant, 1:50) was a
gift from Dr. Joshua Sanes (University of Washington, Seattle, WA).
-galactosidase in clone 2F or actin in
strain RH.
-galactosidase expressed by
strain 2F as previously described (25). To assess the effects of drugs
on attachment, plates were fixed with 2.5% (w/v) formaldehyde for 20 min at 4 °C, washed three times with complete media (Dulbecco's
modified Eagle's medium, 10% FBS, 10 mM HEPES, 2 mM glutamine, 20 µg/ml gentamicin), and then equilibrated
at 37 °C with complete media. This fixation protocol prevents the
majority of parasites from invading while still allowing adhesion to
occur. Parasites were resuspended at 107/ml in invasion
medium and treated for 10 min at room temperature with stock solutions
of drugs. Treated parasites were added in 0.2 ml volume to warm 24-well
plates of human foreskin fibroblasts in quadruplicate and incubated for
20 min at 37 °C for both assays.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-galactosidase in the 2F strain was used to control for inadvertent
lysis of the parasites during the experiment and was typically between
1-5%, as indicated by comparison with dilutions of a parasite cell
standard (% cell stds).

View larger version (25K):
[in a new window]
Fig. 1.
Ryanodine affects calcium-mediated microneme
secretion and increases intracellular calcium. A,
Western blot of parasite supernatants following treatment with RYA
compared with diluted lysates of parasite cell standards (cell
stds). Secretion of MIC2 and MIC4 was stimulated by 1 nM to 10 µM ryanodine, but was inhibited at
100 µM. Tachyzoites were pretreated with the
Ca2+ chelator BAPTA-AM (100 µM) or 10 mM EGTA immediately prior to treatment with ryanodine as
above. Identical blots were probed with monoclonal antibody 6D10
(cellular MIC2 (cMIC2) and secreted MIC2 (sMIC2); upper
panel), 40a-1 mouse anti-
-galactosidase (
-gal;
lower panel), and 5B1 mouse anti-MIC4 (MIC4; lower
panel).
-galactosidase is a cytoplasmic protein used to
indicate parasite lysis. The low molecular weight band visible in the
100% pellet standard is a degradation product. B,
intracellular calcium measurements of fura-2/AM-loaded tachyzoites.
Ryanodine stimulated a greater increase in tachyzoite
[+Ca2+]i in the presence of
extracellular +Ca2+ (+Ca2+) than in
a minimal Ca2+ buffer (+EGTA). Parasite
[+Ca2+]i was monitored in the
presence of 1 mM EGTA (+EGTA) or 1 mM CaCl2 (+Ca2+); 1 µM ryanodine was added where indicated by the
arrow. Lowest trace reflects untreated
parasite [Ca2+]i levels.

View larger version (27K):
[in a new window]
Fig. 2.
Caffeine stimulates microneme secretion and
parasite intracellular calcium. A, Western blot of
parasite supernatants following treatment with caffeine
(CAFF) compared with diluted lysates of parasite cell
standards (cell stds) was performed as in the legend to Fig.
1. 1 µM-1 mM caffeine-stimulated
dose-dependent secretion of MIC2 and MIC4. B,
intracellular calcium measurements of fura-2/AM-loaded tachyzoites.
Tachyzoites loaded with fura-2/AM as described under "Experimental
Procedures," were incubated in buffer A; traces were made in the
presence of 1 mM EGTA or 1 mM CaCl2
(Ca2+); the arrow indicates the point
of addition of 1 mM caffeine (CAFF).

View larger version (28K):
[in a new window]
Fig. 3.
Ethanol increases T. gondii
IP3. A, tachyzoite IP3
levels were monitored by radioreceptor assay at intervals following the
addition of 1% (171 mM) ethanol (+EtOH) or in
control cells (
CTL) as described under "Experimental
Procedures." Ethanol caused a transient increase in parasite
IP3 after its addition. B, Western blot of
parasite protein pellets obtained after IP3 extraction.
Secreted MIC2 (sMIC2) is visible after 1.5 min, while levels
of the cellular form (cMIC2) are unchanged. Both kinetic in
A and Western blot in B are representative of
three independent experiments, which showed similar results.

View larger version (15K):
[in a new window]
Fig. 4.
Xestospongin C inhibits microneme
secretion, attachment, and invasion. A, xestospongin C
caused a dose-dependent inhibition of attachment to and
invasion of host cells. Values are the means + S.E. of three
independent experiments, each with quadruplicate samples. B,
Western blot of parasite supernatants compared with diluted lysates of
parasite cell standards (cell stds) after treatment with
xestospongin C (Xest C) followed by stimulation with 1%
(171 mM) ethanol or 1 mM caffeine. 10 µM xestospongin C inhibited ethanol, caffeine, and basal
(-) stimulation of MIC2 and MIC4. Westerns were performed as described
in the legend to Fig. 1, with parasite actin detected using a rabbit
anti-TgACT1 polyclonal antibody to monitor inadvertent lysis.
C, D, xestospongin C inhibited stimulation of
[Ca2+]i. Tachyzoites loaded with
fura-2/AM were preincubated in buffer A for 3 min in the presence of
Me2SO or 1 µM xestospongin C
(XestC); traces were made in the presence of 1 mM CaCl2. C, the arrow
indicates the addition of 1 mM caffeine (CAFF).
D, the arrow indicates the addition of 100 mM (0.58%) ethanol (EtOH).
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
signaling through tyrosine kinase receptors and PLC-
activated via
heterotrimeric G-proteins (39). Comparisons of PLC isoforms
,
, and
suggest that PLC-
was present in single-celled
eukaryotes, while the
and
forms arose after the development of
multicellular organisms ~940 million years ago (40). Consequently,
parasites likely contain only the ancestral PLC-
isoform. Consistent
with this idea, T. cruzi contains a PLC-
isoform (41) and
PLC-
candidate sequences are present in the Plasmodium
falciparum and Plasmodium vivax genomes (42).
While not conventionally associated with Ca2+ signaling,
PLC-
has recently been linked to Ca2+ transients
associated with fertilization in mice (43). Thus, it is possible that
PLC-
plays an important role in protozoan calcium regulation.

View larger version (21K):
[in a new window]
Fig. 5.
Proposed model for intracellular calcium
signaling in T. gondii. Stimulation of a parasite
signaling cascade during treatment with ethanol or contact with host
cells leads to second messenger IP3 formation, increases in
[Ca2+]i via a calcium release
channel, and microneme secretion. The releasable store of calcium was
not sensitive to thapsigargin, indicating that it may comprise a unique
intracellular pool. IP3R, IP3 receptor.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Drs. Steve Beverley, Vern Carruthers, Dan Goldberg, Andy Pekosz, Paul Schlessinger, and Tom Steinberg for advice and critical input and Jeff Diffenderfer for expert technical assistance.
| |
FOOTNOTES |
|---|
* This work was partially supported by National Institutes of Health Grants 34036 (to L. D. S.) and AI43614 (to S. N. J. M.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§ Partially supported by an Institutional Training Grant AI017172-19 to Washington University.
Recipient of a New Investigator Award in Molecular
Parasitology from the Burroughs Wellcome Fund.
** Recipient of a Scholar Award from the Burroughs Wellcome Fund. To whom correspondence should be addressed: Dept. of Molecular Microbiology, Washington University School of Medicine, Box 8230, St. Louis, MO 63110. Tel.: 314-362-8873; Fax: 314-362-1232; E-mail: sibley@borcim.wustl.edu.
Published, JBC Papers in Press, May 13, 2002, DOI 10.1074/jbc.M202553200
2 J. L. Lovett and L. D. Sibley, unpublished data.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: IP3, D-myo-inositol 1,4,5-triphosphate; BAPTA-AM, 1,2-bis(o-aminophenoxy)ethane-N,N,N',N-tetraacetic acid tetra(acetoxymethyl) ester; PLC, phosphoinositol-specific phospholipase C; RYA, ryanodine.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Carruthers, V. B., and Sibley, L. D. (1997) Eur. J. Cell Biol. 73, 114-123[Medline] [Order article via Infotrieve] |
| 2. | Tomley, F. M., and Soldati, D. S. (2001) Trends Parasitol. 17, 81-88[CrossRef][Medline] [Order article via Infotrieve] |
| 3. | Soldati, D., Dubremetz, J. F., and Lebrun, M. (2001) Int. J. Parasitol. 31, 1293-1302[CrossRef][Medline] [Order article via Infotrieve] |
| 4. | Garcia-Réguet, N., Lebrun, M., Fourmaux, N., Mercereau-Puijalon, O., Mann, T., Beckers, C. J. M., Samyn, B., Van Beeumen, J., Bout, D., and Dubremetz, J. (2000) Cell. Microbiol. 2, 353-364[CrossRef][Medline] [Order article via Infotrieve] |
| 5. | Fourmaux, M. N., Achbarou, A., Mercereau-Puijalon, O., Bderre, C., Brache, I., Loyens, A., Odberg-Ferragut, C., Camus, D., and Dubremetz, J. F. (1996) Mol. Biochem. Parasitol. 83, 201-210[CrossRef][Medline] [Order article via Infotrieve] |
| 6. |
Brecht, S.,
Carruthers, V. B.,
Ferguson, D. J.,
Giddings, O. K.,
Wang, G.,
Jakle, U.,
Harper, J. M.,
Sibley, L. D.,
and Soldati, D.
(2001)
J. Biol. Chem.
276,
4119-4127 |
| 7. |
Carruthers, V. B.,
Håkansson, S.,
Giddings, O. K.,
and Sibley, L. D.
(2000)
Infect. Immun.
68,
4005-4011 |
| 8. | Vieira, M. C., and Moreno, S. N. (2000) Mol. Biochem. Parasitol. 106, 157-162[CrossRef][Medline] [Order article via Infotrieve] |
| 9. | Carruthers, V. B., Giddings, O. K., and Sibley, L. D. (1999) Cell. Microbiol. 1, 225-236[CrossRef][Medline] [Order article via Infotrieve] |
| 10. | Carruthers, V. B., and Sibley, L. D. (1999) Mol. Microbiol. 31, 421-428[CrossRef][Medline] [Order article via Infotrieve] |
| 11. | Carruthers, V. B., Moreno, S. N. J., and Sibley, L. D. (1999) Biochem. J. 342, 379-386[Medline] [Order article via Infotrieve] |
| 12. | Moreno, S. N. J., and Zhong, L. (1996) Biochem. J. 313, 655-659[Medline] [Order article via Infotrieve] |
| 13. | Pingret, L., Millot, J. M., Sharonov, S., Bonhomme, A., Manfait, M., and Pinon, J. M. (1996) J. Histochem. Cytochem. 44, 1123-1129[Abstract] |
| 14. | Brunger, A. T. (2000) Curr. Opin. Neurobiol. 10, 293-302[CrossRef][Medline] [Order article via Infotrieve] |
| 15. | Sorrentino, V., Barone, V., and Rossi, D. (2000) Curr. Opin. Genet. Dev. 10, 662-667[CrossRef][Medline] [Order article via Infotrieve] |
| 16. | Guse, A. H. (1999) Cell. Signal. 11, 309-316[CrossRef][Medline] [Order article via Infotrieve] |
| 17. | Putney, J. W., Jr. (1990) Cell Calcium 11, 611-624[CrossRef][Medline] [Order article via Infotrieve] |
| 18. |
Calvert, C. M.,
and Sanders, D.
(1995)
J. Biol. Chem.
270,
7272-7280 |
| 19. | Passos, A. P., and Garcia, C. R. (1998) Biochem. Biophys. Res. Commun. 245, 155-160[CrossRef][Medline] [Order article via Infotrieve] |
| 20. | Masuda, W., Takenaka, S., Tsuyama, S., Tokunaga, M., Yamaji, R., Inui, H., Miyatake, K., and Nakano, Y. (1997) Comp. Biochem. Physiol. C Pharmacol. Toxicol. 118, 279-283[CrossRef] |
| 21. | Marchesini, N., Bollo, M., Hernández, G., Garrido, M. N., and Machado-Domenech, E. E. (2002) Mol. Biochem. Parasitol. 120, 83-91[CrossRef][Medline] [Order article via Infotrieve] |
| 22. | Thiel, G., MacRobbie, E. A. C., and Hanke, D. E. (1990) EMBO J. 9, 1737-1741[Medline] [Order article via Infotrieve] |
| 23. | Morisaki, J. H., Heuser, J. E., and Sibley, L. D. (1995) J. Cell Sci. 108, 2457-2464[Abstract] |
| 24. | Wan, K. L., Carruthers, V. B., Sibley, L. D., and Ajioka, J. W. (1997) Mol. Biochem. Parasitol. 84, 203-214[CrossRef][Medline] [Order article via Infotrieve] |
| 25. | Dobrowolski, J. M., and Sibley, L. D. (1996) Cell 84, 933-939[CrossRef][Medline] [Order article via Infotrieve] |
| 26. |
Zucchi, R.,
and Ronca-Testoni, S.
(1997)
Pharmacol. Rev.
49,
1-51 |
| 27. |
Carruthers, V. B.,
Sherman, G. D.,
and Sibley, L. D.
(2000)
J. Biol. Chem.
275,
14346-14353 |
| 28. | Wagner-Mann, C., Hu, Q., and Sturek, M. (1992) Br. J. Pharmacol. 105, 903-911[Medline] [Order article via Infotrieve] |
| 29. | Daly, J. W. (2000) J. Auton. Nerv. Syst. 81, 44-52[CrossRef][Medline] [Order article via Infotrieve] |
| 30. |
Kirkman, L. A.,
Weiss, L. M.,
and Kim, K.
(2001)
Infect. Immun.
69,
148-153 |
| 31. | Gafni, J., Munsch, J. A., Lam, T. H., Catlin, M. C., Costa, L. G., Molinski, T. F., and Pessah, I. N. (1997) Neuron 19, 723-733[CrossRef][Medline] [Order article via Infotrieve] |
| 32. |
Sutko, J. L.,
and Airey, J. A.
(1996)
Physiol. Rev.
76,
1027-1071 |
| 33. |
Buck, E.,
Zimanyi, I.,
Abramson, J. J.,
and Pessah, I. N.
(1992)
J. Biol. Chem.
267,
23560-23567 |
| 34. |
Schaloske, R.,
Schlatterer, C.,
and Malchow, D.
(2000)
J. Biol. Chem.
275,
8404-8408 |
| 35. |
Koizumi, S.,
Lipp, P.,
Berridge, M. J.,
and Bootman, M. D.
(1999)
J. Biol. Chem.
274,
33327-33333 |
| 36. |
Wayman, G. A.,
Hinds, T. R.,
and Storm, D. R.
(1995)
J. Biol. Chem.
270,
24108-24115 |
| 37. | Kissmehl, R., Huber, S., Kottwitz, B., Hauser, K., and Plattner, H. (1998) Cell Calcium 24, 193-203[CrossRef][Medline] [Order article via Infotrieve] |
| 38. | Berridge, M. J. (1993) Nature 361, 315-325[CrossRef][Medline] [Order article via Infotrieve] |
| 39. | Berridge, M. J., Lipp, P., and Bootman, M. D. (2000) Nat. Rev. Mol. Cell. Biol. 1, 11-21[CrossRef][Medline] [Order article via Infotrieve] |
| 40. | Koyanagi, M., Ono, K., Suga, H., Iwabe, N., and Miyata, T. (1998) FEBS Lett. 439, 66-70[CrossRef][Medline] [Order article via Infotrieve] |
| 41. |
Furuya, T.,
Kashuba, C.,
Docampo, R.,
and Moreno, S. N.
(2000)
J. Biol. Chem.
275,
6428-6438 |
| 42. |
Bahl, A.,
Brunk, B.,
Coppel, R. L.,
Crabtree, J.,
Diskin, S. J.,
Fraunholz, M. J.,
Grant, G. R.,
Gupta, D.,
Huestis, R. L.,
Kissinger, J. C.,
Labo, P., Li, L.,
McWeeney, S. K.,
Milgram, A. J.,
Roos, D. S.,
Schug, J.,
and Stoeckert, C. J., Jr.
(2002)
Nucleic Acids Res.
30,
87-90 |
| 43. |
Fukami, K.,
Nakao, K.,
Inoue, T.,
Kataoka, Y.,
Kurokawa, M.,
Fissore, R. A.,
Nakamura, K.,
Katsuki, M.,
Mikoshiba, K.,
Yoshida, N.,
and Takenawa, T.
(2001)
Science
292,
920-923 |
| 44. | Raha, S., Dalal, B., Biswas, S., and Biswas, B. B. (1994) Mol. Biochem. Parasitol. 65, 63-71[CrossRef][Medline] [Order article via Infotrieve] |
| 45. | Fabczak, H., Walerczyk, M., Groszynska, G., and Fabczak, S. (1999) Photochem. Photobiol. 69, 254-258 |
| 46. | Matsuoka, T., Moriyama, N., Kida, A., Okuda, K., Suzuki, T., and Kotsuki, H. (2000) J. Photochem. Photobiol. B. Biol. 54, 131-135[CrossRef][Medline] [Order article via Infotrieve] |
| 47. |
Airey, J. A.,
Beck, C. F.,
Murakami, K.,
Tanksley, S. J.,
Deerinck, T. J.,
Ellisman, M. H.,
and Sutko, J. L.
(1990)
J. Biol. Chem.
265,
14187-14194 |
| 48. | Baldauf, S. L., Roger, A. J., Wenk-Siefert, I., and Doolittle, W. F. (2000) Science 290, 972-977[CrossRef][Medline] [Order article via Infotrieve] |
This article has been cited by other articles:
![]() |
A. H. Guse Back from the Dormant Stage: Second Messenger Cyclic ADP-Ribose Essential for Toxoplasma gondii Pathogenicity Sci. Signal., April 29, 2008; 1(17): pe18 - pe18. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nagamune, S. N. J. Moreno, and L. D. Sibley Artemisinin-Resistant Mutants of Toxoplasma gondii Have Altered Calcium Homeostasis Antimicrob. Agents Chemother., November 1, 2007; 51(11): 3816 - 3823. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nagamune, W. L. Beatty, and L. D. Sibley Artemisinin Induces Calcium-Dependent Protein Secretion in the Protozoan Parasite Toxoplasma gondii Eukaryot. Cell, November 1, 2007; 6(11): 2147 - 2156. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. F. Teo, X. W. Zhou, M. Bogyo, and V. B. Carruthers Cysteine Protease Inhibitors Block Toxoplasma gondii Microneme Secretion and Cell Invasion Antimicrob. Agents Chemother., February 1, 2007; 51(2): 679 - 688. [Abstract] [Full Text] [PDF] |
||||
![]() |
E.-M. Ladenburger, I. Korn, N. Kasielke, T. Wassmer, and H. Plattner An Ins(1,4,5)P3 receptor in Paramecium is associated with the osmoregulatory system J. Cell Sci., September 1, 2006; 119(17): 3705 - 3717. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nagamune and L. D. Sibley Comparative Genomic and Phylogenetic Analyses of Calcium ATPases and Calcium-Regulated Proteins in the Apicomplexa Mol. Biol. Evol., August 1, 2006; 23(8): 1613 - 1627. [Abstract] [Full Text] [PDF] |
||||
< |